Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review

Date: July 19, 2016
Pages: 46
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D245E6B8BEEEN
Leaflet:

Download PDF Leaflet

Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review
Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Dottikon ES Holding AG (Dottikon) manufactures and commercializes active pharmaceutical ingredients (APIs), performance chemicals and intermediates for chemical and pharmaceutical industries. The company specializes in hazardous reactions with focus on exothermal reactions, highly reactive compounds or thermally unstable compounds or mixtures. Dottikon uses its technology and equipment to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. It also offers high-purity isosorbide dimethyl ether, which finds application in cosmetics, pharmaceutical, chemical and agricultural industries. It provides recycling and waste management services including recycling of solvents, high-temperature incineration, thermal recovery, and waste water treatment and purification. The company operates through Dottikon ES Group and has subsidiaries in Switzerland and the US. Dottikon is headquartered in Dottikon, Aargau, Switzerland.

Dottikon ES Holding AG Key Recent Developments

Jul 01, 2016: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors
May 31, 2016: DOTTIKON ES – Tenfold Increase in Net Income in Business Year 2015/16
Apr 15, 2016: DOTTIKON ES – Strong Organic Sales Growth in Business Year 2015/16
Mar 11, 2016: DOTTIKON ES – Major Investments and Increase in Headcount in Switzerland
Nov 27, 2015: DOTTIKON ES – Further Increase in Net Sales and Net Income

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Dottikon ES Holding AG - Key Facts
    Dottikon ES Holding AG - Key Employees
    Dottikon ES Holding AG - Key Employee Biographies
    Dottikon ES Holding AG - Major Products and Services
    Dottikon ES Holding AG - History
    Dottikon ES Holding AG - Company Statement
    Dottikon ES Holding AG - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Affiliate

    SECTION 2 – COMPANY ANALYSIS

    Dottikon ES Holding AG - Business Description
    Dottikon ES Holding AG - Corporate Strategy
    Dottikon ES Holding AG - SWOT Analysis
    SWOT Analysis - Overview
    Dottikon ES Holding AG - Strengths
    Strength - Business Performance: Pharmaceutical Products
    Strength - Research and Development (R&D) Capabilities
    Strength - Technology Portfolio
    Strength - Organic Growth
    Dottikon ES Holding AG - Weaknesses
    Weakness - Operations: Performance Chemicals
    Weakness - Dependence on Few Customers
    Dottikon ES Holding AG - Opportunities
    Opportunity - Market Outlook: Active Pharmaceutical Ingridients (APIs)
    Opportunity - Changing Demographics
    Opportunity - Strategic Initiatives
    Dottikon ES Holding AG - Threats
    Threat - Foreign Exchange Fluctuations
    Threat - Intense Competition
    Threat - Stringent Regulations
    Dottikon ES Holding AG - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Dottikon ES Holding AG, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Jul 01, 2016: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors
    May 31, 2016: DOTTIKON ES – Tenfold Increase in Net Income in Business Year 2015/16
    Apr 15, 2016: DOTTIKON ES – Strong Organic Sales Growth in Business Year 2015/16
    Mar 11, 2016: DOTTIKON ES – Major Investments and Increase in Headcount in Switzerland
    Nov 27, 2015: DOTTIKON ES – Further Increase in Net Sales and Net Income
    Jul 03, 2015: DOTTIKON ES' Shareholders Approve all Proposals of the Board of Directors
    May 29, 2015: DOTTIKON ES – Higher Sales and Net Income

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Dottikon ES Holding AG, Key Facts
    Dottikon ES Holding AG, Key Employees
    Dottikon ES Holding AG, Key Employee Biographies
    Dottikon ES Holding AG, Major Products and Services
    Dottikon ES Holding AG, History
    Dottikon ES Holding AG, Subsidiaries
    Dottikon ES Holding AG, Affiliate
    Dottikon ES Holding AG, Key Competitors
    Dottikon ES Holding AG, Ratios based on current share price
    Dottikon ES Holding AG, Annual Ratios
    Dottikon ES Holding AG, Interim Ratios
    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Dottikon ES Holding AG, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Dottikon ES Holding AG, Performance Chart (2012 - 2016)
    Dottikon ES Holding AG, Ratio Charts
    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Dottikon ES Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Dottikon ES Holding AG (DESN) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: